Transcend Capital Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Transcend Capital Advisors, LLC

$1.35 Billion
Q4 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 49,350 shares of XBI stock, worth $4.33 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

49,350

Previous 50,834 2.92%

Holding current value

$4.33 Million

Previous $5.02 Million 11.51%

% of portfolio

0.33%

Previous 0.35%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$89.81 - $104.0 $133,278 - $154,336	-1,484 Reduced 2.92%	49,350 $4.44 Million
Q3 2024 Oct 15, 2024	SELL	$90.87 - $102.43 $297,599 - $335,458	-3,275 Reduced 6.05%	50,834 $5.02 Million
Q2 2024 Jul 02, 2024	BUY	$82.22 - $94.12 $310,298 - $355,208	3,774 Added 7.5%	54,109 $5.02 Million
Q1 2024 May 03, 2024	BUY	$87.05 - $102.89 $185,503 - $219,258	2,131 Added 4.42%	50,335 $4.78 Million
Q4 2023 Feb 05, 2024	BUY	$64.12 - $90.86 $1.06 Million - $1.51 Million	16,605 Added 52.55%	48,204 $4.3 Million
Q3 2023 Oct 31, 2023	BUY	$71.88 - $85.76 $1.35 Million - $1.61 Million	18,820 Added 147.27%	31,599 $2.31 Million
Q2 2023 Jul 13, 2023	SELL	$75.38 - $90.23 $1,959 - $2,345	-26 Reduced 0.2%	12,779 $1.06 Million
Q1 2023 Apr 12, 2023	SELL	$73.13 - $91.97 $65,597 - $82,497	-897 Reduced 6.55%	12,805 $975,000
Q4 2022 Jan 20, 2023	SELL	$76.72 - $85.66 $379,380 - $423,588	-4,945 Reduced 26.52%	13,702 $0
Q3 2022 Oct 17, 2022	BUY	$75.06 - $94.9 $9,157 - $11,577	122 Added 0.66%	18,647 $1.48 Million
Q2 2022 Jul 12, 2022	BUY	$62.81 - $96.09 $216,192 - $330,741	3,442 Added 22.82%	18,525 $1.38 Million
Q1 2022 Apr 20, 2022	SELL	$81.07 - $115.44 $10,052 - $14,314	-124 Reduced 0.82%	15,083 $1.36 Million
Q4 2021 Jan 20, 2022	BUY	$108.77 - $134.15 $1.12 Million - $1.38 Million	10,262 Added 207.52%	15,207 $1.7 Million
Q3 2021 Nov 04, 2021	BUY	$118.69 - $138.49 $586,922 - $684,833	4,945 New	4,945 $613,000
Q2 2021 Aug 13, 2021	SELL	$122.48 - $139.69 $767,337 - $875,157	-6,265 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$129.36 - $173.99 $4,268 - $5,741	33 Added 0.53%	6,265 $851,000
Q4 2020 Feb 12, 2021	SELL	$110.36 - $151.14 $158,697 - $217,339	-1,438 Reduced 18.75%	6,232 $877,000
Q3 2020 Nov 13, 2020	BUY	$103.87 - $120.36 $796,682 - $923,161	7,670 New	7,670 $855,000

Others Institutions Holding XBI

# of Institutions

914

Shares Held

102M

Call Options Held

27.4M

Put Options Held

38.6M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History